Found 71 matching trials
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
PHASE2This is a single-arm, single-center feasibility trial of patients with bord...
Location
Juravinski Hospital
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
PHASE3The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients ...
Status
Active Not Recruiting
Location
Jeroen Bosch Hospital
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
PHASE1A first in human study to evaluate the safety and preliminary antitumor act...
Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
PHASE2Surgical resection is the only potentially curative treatment for patients ...
Location
Smilow Cancer Hospital
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
PHASE2This is a phase II, multicenter, double-blinded, randomized, 2-arm trial ev...
Location
Mayo Clinic-Arizona
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
PHASE3The main purpose of
* To observe the overall survival of patients with res...
Location
Multiple Locations
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1The investigators hypothesize that MK2 inhibition may improve efficacy of m...
Location
Washington University School of Medicine
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
PHASE1The researchers are doing this study to find out whether ELI-002 7P in comb...
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)
PHASE3The main aim of this study is to compare the efficacy of short-course versu...
Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
PHASE2This study is being done to evaluate the safety and efficacy of adding NIS7...
Location
Brigham and Women's Hospital